JAM2 / JAMB / CD322 Immunizing Peptide[JAM2 / JAMB / CD322]

Products_type

Peptide
Products_gene_name

[JAM2]
Reactivity

Human, Mouse, Rat, Dog, Cow
Description

Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.

Gene target

JAM2 JAMB CD322 Immunizing Peptide[JAM2 JAMB CD322]
Gene symbol

JAM2, LINC01684
Short name

JAM2 / JAMB / CD322 Immunizing Peptide[JAM2 / JAMB / CD322]
Technique

peptide, peptides
Alternative name

junctional adhesion molecule 2 / JAMB / CD322 Immunizing short protein sequence[junctional adhesion molecule 2 / JAMB / CD322]
Alternative technique

peptides
Alternative to gene target

junctional adhesion molecule 2, JAM2 and IDBG-1072 and ENSG00000154721 and 58494, protein heterodimerization activity, Cell surfaces, Jam2 and IDBG-172706 and ENSMUSG00000053062 and 67374, JAM2 and IDBG-630318 and ENSBTAG00000000603 and 538846

Identity

HGNC:14686
Gene

JAM2
Long gene name

junctional adhesion molecule 2
Synonyms gene
- C21orf43
Synonyms
- VE-JAM
- JAM-B
- JAMB
- CD322
GenBank acession
- AF255910
Locus

21q21.3
Discovery year

2001-04-25
Entrez gene record

58494
Pubmed identfication
- 10779521
- 10945976
Classification
- CD molecules
- Ig-like cell adhesion molecule family
- I-set domain containing
- V-set domain containing
VEGA ID

OTTHUMG00000078441